A Phase 2 Randomized Study of LY2541546 versus Placebo in Postmenopausal Women with Low Bone Mineral Density:An Evaluation of the Dose Response Relationship Using Bone Mineral Density
Phase 2
Completed
- Conditions
- Osteoporosis
- Registration Number
- JPRN-jRCT2080221242
- Lead Sponsor
- Eli Lilly Japan K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Have low BMD, defined as a T-score for lumbar spine of between -3.5 and -2.0, inclusive, based on the local DXA report as interpreted by the investigator. The method of determining Tscore values will be based on regional standards. Three of 4 vertebrae, L1 through L4, must be evaluable for BMD scoring, as measure by DXA.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method